Long-term stability of fibrinolytic factors stored at -80 degrees C. 2010

Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. jenny.hernestal-boman@medicin.umu.se

BACKGROUND Blood samples in epidemiological studies are often stored for several years and analysed at different occasions. The reagent kits are continually modified for better precision and accuracy. Our hypothesis was that epidemiological studies are affected by long-term storage and/or modifications of reagent kits. METHODS Plasma samples stored at -80( degrees )C from two populations were used: A case-referent study with samples collected from 1985 to 2000 and analysed 2005 (n=1598) were used to study influence of long-term storage. A cross-sectional study analysed 1990 (n=1558) and re-analysed 2001 (n=78) and 2005 (n=828) was used to study influence of reagent kit modifications. Fibrinolytic analyses included immunoassays of tPA, PAI-1 and tPA-PAI-1 complex and chromogenic substrate assays of the activities of tPA and PAI-1. RESULTS Long-term storage for a median time of 11.6 years (range 5 to 20) showed an effect of time on tPA antigen R(2)=0.01, PAI-1 antigen R(2)=0.01 and tPA-PAI-1 complex R(2) = 0.02. Modifications in reagent kits affected the levels of fibrinolytic factors; for tPA antigen the slope coefficients were between 0.72 and 0.95 (R(2) 0.47 - 0.75), whereas tPA activity showed an agreement with slope coefficients 1.06 to 1.09 (R(2) 0.67 - 0.93). CONCLUSIONS This study showed that long-term storage affects fibrinolytic variables to a negligible extent, but modifications in reagent kits introduced an element of bias. We conclude that analysis of samples on a single occasion is preferable to multiple occasions, as storage has negligible effect.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D001800 Blood Specimen Collection The taking of a blood sample to determine its character as a whole, to identify levels of its component cells, chemicals, gases, or other constituents, to perform pathological examination, etc. Blood Specimen Collections,Collection, Blood Specimen,Collections, Blood Specimen,Specimen Collection, Blood,Specimen Collections, Blood
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D004867 Equipment Design Methods and patterns of fabricating machines and related hardware. Design, Equipment,Device Design,Medical Device Design,Design, Medical Device,Designs, Medical Device,Device Design, Medical,Device Designs, Medical,Medical Device Designs,Design, Device,Designs, Device,Designs, Equipment,Device Designs,Equipment Designs
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019544 Equipment Failure Analysis The evaluation of incidents involving the loss of function of a device. These evaluations are used for a variety of purposes such as to determine the failure rates, the causes of failures, costs of failures, and the reliability and maintainability of devices. Materials Failure Analysis,Prosthesis Failure Analysis,Analysis, Equipment Failure,Analysis, Materials Failure,Analysis, Prosthesis Failure,Analyses, Equipment Failure,Analyses, Materials Failure,Analyses, Prosthesis Failure,Equipment Failure Analyses,Failure Analyses, Equipment,Failure Analyses, Materials,Failure Analyses, Prosthesis,Failure Analysis, Equipment,Failure Analysis, Materials,Failure Analysis, Prosthesis,Materials Failure Analyses,Prosthesis Failure Analyses

Related Publications

Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
January 2002, Journal of analytical toxicology,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
December 2009, Clinical journal of the American Society of Nephrology : CJASN,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
January 2008, Clinical chemistry and laboratory medicine,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
January 2003, Laboratory hematology : official publication of the International Society for Laboratory Hematology,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
October 1999, Journal of analytical toxicology,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
August 2002, Clinica chimica acta; international journal of clinical chemistry,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
July 2012, Clinical biochemistry,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
July 2001, Endocrine,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
December 1996, Mutation research,
Jenny Hernestål-Boman, and Jan-Håkan Jansson, and Torbjörn K Nilsson, and Mats Eliasson, and Lars Johansson
June 2009, BMC research notes,
Copied contents to your clipboard!